Advair
Product Images NDC 33261-873
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Advair (NDC 33261-873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Advair Diskus For Glaxosmithkline 10)
Figure 2 (Advair Diskus For Glaxosmithkline 11)
Figure 3 (Advair Diskus For Glaxosmithkline 12)
Figure 4 (Advair Diskus For Glaxosmithkline 13)
Figure 5 (Advair Diskus For Glaxosmithkline 14)
Figure 6 (Advair Diskus For Glaxosmithkline 15)
Image Label (Advair Diskus For Glaxosmithkline 16)
This is a description of a medication called Advair Diskus, which is a generic version of the drug with the same name. The medication is distributed by Aidarex Pharmaceuticals LLC and contains Fluticasone Propionate with a strength of 100mcg, and Salmeterol with a strength of 50mcg. The medication is available in the form of inhalation powder, intended for use twice daily. The medication is manufactured by GlaxoSmithKline in Triangle Park, North Carolina. The description includes NDC numbers for different dosages and quantities of the medication.*
Image Label (Advair Diskus For Glaxosmithkline 17)
This is a description of a medication named "ADVAIR DISKUS". The medication is an inhalation powder used twice a day, containing Fluticasone Propionate and Salmeterol. The dosage is 250/50mcg with 60 doses in a package. The manufacturer is GlaxoSmithKline located in Triangle Park, NC 27709, and the product is distributed by AIDAREX PHARMACEUTICALS LLC. The package has NDC code: 33261-0874-01, and the prescription number is 1001024529.*
Fluticasone Propionate Chemical Structure (Advair Diskus For Glaxosmithkline 2)
Salmeterol Xinafoate Chemical Structure (Advair Diskus For Glaxosmithkline 3)
Figure 2. Mean Percent Change From Baseline In Fev1 In Patients With Asthma Previously Treated With Either Inhaled Corticosteroids Or Salmeterol (study 1) (Advair Diskus For Glaxosmithkline 4)
Figure 3. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (Advair Diskus For Glaxosmithkline 5)
Figure 4. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (Advair Diskus For Glaxosmithkline 6)
Figure 5. Predose Fev1: Mean Percent Change From Baseline In Patients With Chronic Obstructive Pulmonary Disease (Advair Diskus For Glaxosmithkline 7)
Figure 6. Two-hour Postdose Fev1: Mean Percent Changes From Baseline Over Time In Patients With Chronic Obstructive Pulmonary Disease (Advair Diskus For Glaxosmithkline 8)
This appears to be a pharmaceutical document showing the effectiveness of different medications in treating a respiratory condition. The medications are Adavair Diskus 250/50, Fluticasone Propionate 250mcg daily, and Placebo. The document includes baseline FEV (forced expiratory volume) for each medication and some numerical data, but it is not clear what the data represents.*
Diskus Parts (Advair Diskus For Glaxosmithkline 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.